This is a business champ, nothing more and nothing less. What we do, how we do it, whose expectations were met and whose were broken are secondary (if not immaterial) to the reasons this Company - any Company - is created.
We're here to make money, nothing else. That's the purpose of the scoping study, to predict cash flows, in and out. To give you some idea of the value of those cash flows in today's dollars.
Furthermore, the Mannheim process, which you consistently point to and deride is responsible for half the world's production. It makes no difference to those Companies which go down that path. All that matters is whether or not they are profitable, is the share price justified by the free cash flow they create.
Without Mannheim we don't have gate prices between $900 and $1100 in Australia. Without Mannheim we don't have these margins and these opportunities.
Can you give me a list of major (brine extracted) SOP producers around the world, which you are aware of, that do not use the excess sulphates generated in the production process to value add?
Just give me a list, as an expression of your concern for the shareholders here, I'll do the DD.
Stay tuned.
Proc.
- Forums
- ASX - By Stock
- APC
- Ann: Exceptionally Strong Scoping Study Findings
Ann: Exceptionally Strong Scoping Study Findings, page-57
-
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add APC (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.070M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
APC (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online